Although there are studies that estimate that elevations in PSA can precede clinical manifestations of prostate cancer by five to 10 years [6,7], it is known that it can be elevated in the absence of prostate cancer in men with benign pathology (such as benign prostatic hyperplasia) or acute pathology (such as prostatitis). This evidence concerns the gene KLK3 and benign prostatic hyperplasia.